Marjorie G Zauderer

14PUBLICATIONS
161CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

|Mar 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Jan 13, 2026
A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer.

Brinda Alagesan, Anna M Varghese, Celina Ang

|Sep 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.

Wungki Park, Catherine O'Connor, Joanne Chou

|Jan 03, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.

Anna M Varghese, Maria A Perry, Joanne F Chou

Pageof 3

Frequent Collaborators

10 joint publications

Eileen O'Reilly

7 joint publications

Michael F Berger

7 joint publications

Wungki Park

6 joint publications

Christine Iacobuzio-Donahue